tradingkey.logo

Nanovibronix Inc

NAOV
查看详细走势图
4.020USD
0.000
收盘 12/24, 13:00美东报价延迟15分钟
4.06M总市值
亏损市盈率 TTM

Nanovibronix Inc

4.020
0.000
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

0.00%

5天

0.00%

1月

-2.66%

6月

-56.62%

今年开始到现在

-93.81%

1年

-93.17%

查看详细走势图

TradingKey Nanovibronix Inc股票评分

单位: USD 更新时间: 2025-12-11

操作建议

Nanovibronix Inc当前公司基本面数据相对非常健康,增长潜力很大。当前估值合理,在医疗设备与耗材行业排名154/209位。机构持股占比很高,中期看,股价处于下降通道。近一个月,市场表现较差,基本面和技术面综合得分也较低。目前股价在压力位和支撑位之间,可以做区间波段操作。

Nanovibronix Inc评分

相关信息

行业排名
154 / 209
全市场排名
463 / 4593
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

分析师目标

根据 0 位分析师
--
评级
0.000
目标均价
0.00%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Nanovibronix Inc亮点

亮点风险
NanoVibronix, Inc. is a medical device company focused on developing medical devices utilizing its patented low intensity surface acoustic wave (SAW) technology. The technology allows for the creation of low-frequency ultrasound waves that can be utilized for a variety of medical applications, including for disruption of biofilms and bacterial colonization, as well as for pain relief. The Company's primary products include PainShield and UroShield, which are portable devices suitable for administration at home or in any care setting. PainShield is a patch-based therapeutic ultrasound technology to treat pain, muscle spasm and joint contractures by delivering a localized ultrasound effect to treat pain and induce soft tissue healing in a targeted area. UroShield is an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters, increase antibiotic efficacy and decrease pain and discomfort associated with urinary catheter use.
业绩高增长
公司营业收入稳步增长,连续3年增长240.16%
业绩增长期
公司处于发展阶段,最新年度总收入2.56M美元
估值高估
公司最新PE估值-0.08,处于3年历史高位
机构加仓
最新机构持股5.95K股,环比增加28.25%
詹姆斯·西蒙斯持仓
明星投资者詹姆斯·西蒙斯持仓,最新持仓市值0.00
活跃度降低
近期活跃度降低,过去20天平均换手率-0.99

Nanovibronix Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Nanovibronix Inc简介

NanoVibronix, Inc. is a medical device company focused on developing medical devices utilizing its patented low intensity surface acoustic wave (SAW) technology. The technology allows for the creation of low-frequency ultrasound waves that can be utilized for a variety of medical applications, including for disruption of biofilms and bacterial colonization, as well as for pain relief. The Company's primary products include PainShield and UroShield, which are portable devices suitable for administration at home or in any care setting. PainShield is a patch-based therapeutic ultrasound technology to treat pain, muscle spasm and joint contractures by delivering a localized ultrasound effect to treat pain and induce soft tissue healing in a targeted area. UroShield is an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters, increase antibiotic efficacy and decrease pain and discomfort associated with urinary catheter use.
公司代码NAOV
公司Nanovibronix Inc
CEOBesser (Doron)
网址https://nanovibronix.com/

常见问题

Nanovibronix Inc(NAOV)的当前股价是多少?

Nanovibronix Inc(NAOV)的当前股价是 4.020。

Nanovibronix Inc的股票代码是什么?

Nanovibronix Inc的股票代码是NAOV。

Nanovibronix Inc股票的52周最高点是多少?

Nanovibronix Inc股票的52周最高点是162.500。

Nanovibronix Inc股票的52周最低点是多少?

Nanovibronix Inc股票的52周最低点是3.550。

Nanovibronix Inc的市值是多少?

Nanovibronix Inc的市值是4.06M。

Nanovibronix Inc的净利润是多少?

Nanovibronix Inc的净利润为-3.71M。

现在Nanovibronix Inc(NAOV)的股票是买入、持有还是卖出?

根据分析师评级,Nanovibronix Inc(NAOV)的总体评级为--,目标价格为--。

Nanovibronix Inc(NAOV)股票的每股收益(EPS TTM)是多少

Nanovibronix Inc(NAOV)股票的每股收益(EPS TTM)是-51.786。
KeyAI